Skip to content
Research article in American Journal of Hematology 2022 – HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy
Home/Publications & abstracts/Research article in American Journal of Hematology 2022 – HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy
Research article in American Journal of Hematology 2022 – HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy
webmaster@ervaccinetechnologies.com2022-06-28T22:19:48+00:00
Share on your favorite plateform
Page load link